Study objective: Risk factors associated with treatment failure and mu
ltidrug-resistant tuberculosis (MDR-TB) were examined among HIV-serone
gative patients who were previously treated for tuberculosis (TB). Des
ign: Prospective, cohort study of patients referred to the study hospi
tal for retreatment of TB between March 1986 and March 1990. Patients:
The patients belonged to three groups, according to outcomes followin
g their previous treatment: 37 patients who abandoned treatment car su
ffered release after completion of therapy (group A), 91 patients who
failed to respond to the first-line drug regimen (group B), and 78 pat
ients who failed to respond to the second-line drug regimen (group C),
Results: Patients with Mycobacterium tuberculosis strains resistant t
o rifampin and isoniazid were found in 2 (6%) in group A, 29 (33%) in
group B, and 49 (65%) in group C, Cure was achieved in 77% in group A,
54% in group B, and 36% in group C. Death occurred in none of the pat
ients in group A, 8% in group B, and 24% in group C. Inn a multivariat
e logistic regression analysis, unfavorable response (failure to steri
lize sputum culture, death, and abandonment) was significantly associa
ted with infection with a multidrug-resistant M tuberculosis strain (p
= 0.0002), cavitary disease (p = 0.0029), or irregular use of medicat
ions (p < 0.0001). Conclusion: These observations show that a previous
treatment outcome and current clinical and epidemiologic histories ca
n be used to predict the development of MDR-TB and adverse outcomes in
patients undergoing retreatment for TB. Such information may be usefu
l for identifying appropriate patient candidates for programs such as
directly observed therapy.